Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 4, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Brilliant blue in vitreoretinal surgery.

Hiroshi Enaida1, Tatsuro Ishibashi

  • 1Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, and Department of Ophthalmology, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Developments in Ophthalmology
|June 7, 2008
PubMed
Summary

Brilliant Blue G (BBG) shows low toxicity and effectively stains the internal limiting membrane (ILM) during retinal surgery. This dye aids in visualizing and peeling the ILM, improving surgical outcomes without adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial.

PloS one·2026
Same author

RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD.

Investigative ophthalmology & visual science·2026
Same author

Exploratory investigation of OCTA-VISTA for longitudinal monitoring of neovascular age-related macular degeneration treatment.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Observation of Blood Flow Velocity Signals in Retinal Astrocytic Hamartoma Using OCTA-VISTA B Scan.

Retina (Philadelphia, Pa.)·2025
Same author

Detailed Vascular Architecture and Flow in Congenital Retinal Macrovessels Observed With a Prototype High-Speed, High-Resolution Swept Source OCT.

Retina (Philadelphia, Pa.)·2025
Same author

En-face quantitative evaluation using ultra-high-resolution OCT of hyperreflective foci in neovascular age-related macular degeneration.

Japanese journal of ophthalmology·2025

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Ophthalmic Dyes

Background:

  • Vitreoretinal surgery often requires clear visualization of the internal limiting membrane (ILM).
  • Existing dyes may have limitations in safety or efficacy for ILM staining.

Purpose of the Study:

  • To evaluate the preclinical safety and efficacy of Brilliant Blue G (BBG) for retinal applications.
  • To assess BBG's utility in visualizing and peeling the ILM during vitreoretinal surgery in a pilot clinical study.

Main Methods:

  • Preclinical assessment involved intravitreous injection of BBG in rat eyes, followed by morphological and functional analyses (light/electron microscopy, TUNL staining, ERG).
  • Primate and human clinical studies involved BBG staining for ILM visualization and peeling during vitreoretinal surgery.

More Related Videos

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Related Experiment Videos

Last Updated: Jul 4, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Main Results:

  • Preclinical studies showed BBG had low toxicity, with minimal retinal cell vacuolization at high doses but no functional impairment (ERG).
  • BBG clearly visualized the ILM in primate and human eyes, facilitating successful peeling.
  • Clinical outcomes showed improved postoperative visual acuity in most patients with no observed adverse effects.

Conclusions:

  • Brilliant Blue G (BBG) is a safe and effective dye for intraoperative visualization of the ILM in vitreoretinal surgery.
  • BBG's low toxicity, strong staining ability, and ease of handling make it a valuable tool for retinal surgery.